AMN5-Corrected iPSC
SCHi001-A-1
General
Cell Line |
|
hPSCreg name | SCHi001-A-1 |
Cite as: | SCHi001-A-1 (RRID:CVCL_C0EY) |
Alternative name(s) |
AMN5-Corrected iPSC
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
|
Last update | 26th October 2021 |
User feedback | |
Provider |
|
Generator | Severance Children’s Hospital (SCH) |
External Databases |
|
BioSamples | SAMEA10454450 |
Cellosaurus | CVCL_C0EY |
Wikidata | Q112930590 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
No |
Subclone of |
Donor Information
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA10405029 |
Ethics
Also have a look at the ethics information for the parental line
SCHi001-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
SCHi001-A.
|
|
Reprogramming method |
|
Vector type | Integrating |
Vector | Plasmid |
Is the used vector excisable? |
Unknown |
Absence of reprogramming vector(s)? |
Unknown |
Reprogramming vectors silenced? | |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Medium |
mTeSR™ 1
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|||||
SOX2 |
Yes |
|||||
SSEA-4 |
Yes |
|||||
POU5F1 (OCT-4) |
Yes |
|||||
TRA 1-60 |
Yes |
|||||
TRA 1-81 |
Yes |
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
g-banding
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.